From Discovery to the Clinic: Safety Evaluation of Ocular Therapeutics


Tuesday, February 2, 2021
08:00 AM EST / 14:00 CET


Virtual Seminar
Optical coherence tomography


Even if you’ve considered route of delivery, frequency and duration of treatment, and the nature of your API, a thorough preclinical safety assessment of innovative ocular therapies can be challenging. Few organizations have the internal resources or knowledge to obtain the data required for approval, much less perform these evaluations with any efficiency.

Learn how to minimize risk to patients and your program during our special 1-hour presentation. You’ll discover the data, study designs, and technologies that will help you satisfy rigorous regulatory requirements and meet the ocular toxicologists with the knowledge and experience to support your program. We hope you will join us.


Seminar Presenters

Mark Vézina Headshot

Mark Vézina, BSc
Director, Ocular and Neuroscience

Philippe Ancian Headshot

Philippe Ancian, PhD
Senior Director, Biomarkers